NPP has been used mainly in the treatment of advanced breast cancer in women and as an adjunct therapy for the treatment of senile or postmenopausal osteoporosis in women. Historically, it has also had a variety of other uses. Because of its reduced androgenic effects, the drug has not generally been used in androgen replacement therapy for androgen deficiency in men and has instead been used for solely for anabolic indications. However, nandrolone esters have more recently been proposed for the treatment of androgen deficiency in men due to favorable properties including their high ratio of anabolic to androgenic effects and consequent much lower risk of prostate enlargement, prostate cancer, and scalp hair loss relative to testosterone. Available forms NPP is or has been available 25 mg/mL and 50 mg/mL formulations in oil solution for intramuscular injection.
Nandrolone phenylpropionate
Nandrolone furylpropionate
Androstanolone benzoate
Androstanolone enanthate
Drostanolone propionate
Androstanolone propionate
Nandrolone cyclohexylpropionate
Norethisterone enanthate